Literature DB >> 915017

Standardisation of a simple method for the determination of antithrombin activity.

A Frigola.   

Abstract

A procedure is described for performing a functional assay of serum antithrombin activity. The method consists of adding serum to a thrombin solution and measuring, after a fixed incubation time, the residual thrombin activity on a substrate plasma. The mean serum antithrombin activity found in 96 healthy blood donors using this procedure was 109.5% (range 82%-160%). The method was linear over an activity range between 30.5% and 176%, was significantly correlated with antithrombin-III protein concentration determined by radial immunodiffusion (r = 0.86, P less than 0.01), and showed good reproducibility (coefficient of variation 2.7%). On account of its simplicity and precision this functional assay should be of considerable use in evaluating hypercoagulability.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 915017      PMCID: PMC476580          DOI: 10.1136/jcp.30.9.881

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA.

Authors:  O EGEBERG
Journal:  Thromb Diath Haemorrh       Date:  1965-06-15

2.  Identity of plasma-activated factor X inhibitor with antithrombin 3 and heparin cofactor.

Authors:  E T Yin; S Wessler; P J Stoll
Journal:  J Biol Chem       Date:  1971-06-10       Impact factor: 5.157

3.  Antithrombin 3 and diseases.

Authors:  E Von Kaulla; K N Von Kaulla
Journal:  Am J Clin Pathol       Date:  1967-07       Impact factor: 2.493

4.  A new two-stage functional assay for antithrombin-III (heparin cofactor): clinical and laboratory evaluation.

Authors:  R L Bick; I Kovacs; L F Fekete
Journal:  Thromb Res       Date:  1976-06       Impact factor: 3.944

5.  Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma.

Authors:  U Abildgaard; M K Fagerhol; O Egeberg
Journal:  Scand J Clin Lab Invest       Date:  1970-12       Impact factor: 1.713

6.  Serum antithrombin in coronary-artery disease.

Authors:  I Innerfield; J D Goldfischer; H Reicher-Reiss; J Greenberg
Journal:  Am J Clin Pathol       Date:  1976-01       Impact factor: 2.493

7.  Antithrombin III, heparin cofactor and antifactor Xa in a clinical material.

Authors:  O R Odegård; A N Teien
Journal:  Thromb Res       Date:  1976-02       Impact factor: 3.944

  7 in total
  2 in total

1.  Determination of antithrombin activity by an amidolytic and a clotting procedure.

Authors:  A Frigola; S Angeloni; A R Cerqueti
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

2.  Comparison of three methods for the estimation of plasma antithrombin.

Authors:  D S McLellan; J D Devlin; G H Heyse-Moore; A Aronstam
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.